3 results

• Valeant Eye Drop Approval Held Up Over Manufacturing Concerns Following FDA Inspection

  July 26, 2016

  Irvin Jackson

  The FDA has issued a letter to Valeant indicating that a Bausch and Lomb facility in Florida has failed to meet current good manufacturing practices, potentially holding up a new eye drop drug to treat glaucoma.

• Drug Company Advertising Skyrocketed In 2015: Report

  July 8, 2016

  Irvin Jackson

  The pharmaceutical industry is expanding its advertising spending at a rate faster than any other industry, at a time when some health experts say direct-to-consumer ads for prescription drugs should be banned.

• Potiga Risk of Vision Loss, Skin Discoloration Require New Long-Term Study

  June 17, 2015

  Irvin Jackson

  The FDA has ordered the makers of Potiga to conduct a long-term study on skin discoloration and retina pigment changes caused by the epilepsy drug.